Medpace shareholders approve charter amendments removing supermajority voting and special meeting restrictions

Medpace Holdings, Inc.

Shareholders approved removal of supermajority voting requirements (24.3M for, 95k against); effective May 18, 2026.
Approved removal of limitation on stockholders calling special meetings; new bylaws require 25% continuous ownership for one year.
Non-binding stockholder proposal on special meetings defeated (8.3M for, 16.1M against); board recommended against.
Advisory say-on-pay passed (22.7M for, 1.7M against); frequency set to annual, consistent with board recommendation.
All five director nominees elected; Deloitte & Touche ratified as auditor for fiscal 2026.

item 5.03item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.